Health Care: Drugs

PDL BioPharma Inc. (PDLI: NASDAQ)

$8.23 0.02 | 0.24%
05/21/13 - 09:30 AM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 374.52M 362.04M 344.98M 318.18M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 374.52M 362.04M 344.98M 318.18M
Selling, General, and Administrative Expenses 25.47M 18.34M 133.90M 21.06M
Research & Development 0.00 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 349.06M 343.70M 211.08M 297.12M
Depreciation & Amortization 14.65M 11.32M 9.25M 4.41M
Interest Income 7.11M 593.00K 468.00K 1.00M
Other Income - Net 0.00 -766.00K -17.65M 1.52M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 341.52M 332.21M 184.65M 295.24M
Interest Expense 29.04M 36.10M 43.53M 19.36M
Pre-Tax Income 312.48M 296.10M 141.12M 275.88M
Income Taxes 115.46M 108.04M 58.50M 90.62M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 211.67M 199.39M 91.87M 189.66M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 211.67M 199.39M 91.87M 189.66M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 211.67M 199.39M 91.87M 189.66M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 211.67M 199.39M 91.87M 189.66M
Preferred Dividends
Net Income Available To Common 211.67M 199.39M 91.87M 189.66M
Basic EPS from Continuing Ops. 1.52 1.43 0.73 1.59
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.52 1.43 0.73 1.59
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.52 1.43 0.73 1.59
Basic Normalized Net Income/Share 1.52 1.43 0.73 1.59
EPS fr Continuing Ops. 1.45 1.15 0.54 1.07
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.45 1.15 0.54 1.07
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.45 1.15 0.54 1.07
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 1.45 1.15 0.54 1.07
Dividends Paid per Share 0.60 0.60 1.00 2.67

Portfolios with PDLI

View All

Latest PDLI Headlines from TheStreet

More Financial News for PDLI

Press Releases for PDLI

See All Press Releases

Partner Headlines for PDLI

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter